Archive for the ‘Malaria’ Category
Malaria outbreak spreads in drug-short Venezuela
Sunday, November 26th, 2017“…..The government has not given an overall death toll. But health
activists and doctor groups estimate that around 200 people have died
from malaria over the last year [2016] nationwide, and fear the
illness is starting to afflict populated urban centers…….
The regional arm of the World Health Organization last month [October
2017] announced the arrival of over one million anti-malarial pills,
which doctors deem insufficient. Patients must visit their nearest
health center up to 4 times to complete treatment in what officials
say is an attempt to avoid feeding the black market for drugs……”
EPA Registers the Wolbachia ZAP Strain in Live Male Asian Tiger Mosquitoes in order to reduce their population thereby reducing the spread numerous diseases of significant human health concern
Thursday, November 9th, 2017
For Release: November 7, 2017
On November 3, 2017, EPA registered a new mosquito biopesticide – ZAP Males® – that can reduce local populations of the type of mosquito (Aedes albopictus, or Asian Tiger Mosquitoes) that can spread numerous diseases of significant human health concern, including the Zika virus.
ZAP Males® are live male mosquitoes that are infected with the ZAP strain, a particular strain of the Wolbachia bacterium. Infected males mate with females, which then produce offspring that do not survive. (Male mosquitoes do not bite people.) With continued releases of the ZAP Males®, local Aedes albopictus populations decrease. Wolbachia are naturally occurring bacteria commonly found in most insect species.
This time-limited registration allows MosquitoMate, Inc. to sell the Wolbachia-infected male mosquitoes for five years in the District of Columbia and the following states: California, Connecticut, Delaware, Illinois, Indiana, Kentucky, Massachusetts, Maine, Maryland, Missouri, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, Tennessee, Vermont, and West Virginia. Before the ZAP Males® can be used in each of those jurisdictions, it must be registered in the state or district.
When the five-year time limit ends, the registration will expire unless the registrant requests further action from EPA.
EPA’s risk assessments, along with the pesticide labeling, EPA’s response to public comments on the Notice of Receipt, and the proposed registration decision, can be found on www.regulations.gov under docket number EPA-HQ-OPP-2016-0205.
Italy: 4 cases of locally transmitted P. falciparum malaria
Thursday, October 12th, 2017Malaria Outbreak in Ginosa, Italy
On October 3, 2017, Italy reported four cases of locally transmitted P. falciparum malaria among migrant agricultural workers in Ginosa, which is in the Taranto Province of the Apulia region of Italy. The four patients were males, between 21–37 years of age, and lived in camps with other migrant workers in the Ginosa area. Three of the patients were from Morocco where there is no malaria, and one is from Sudan which is a malaria-endemic country. All reported no travel for the past two months. Italian public health authorities continue to investigate this outbreak.
Italy was declared free of malaria by the World Health Organization in 1970. However, the mosquitoes that transmit malaria, specifically Anopheles labrachiae, An. manulipennis, An. superpictus, and possibly An. sacharovi, are present. Thus, rare autochthonous cases have been reported including P. vivax in Tuscany in 1997 and P. vivax in Latina Province in 2009.
Given the focal, limited nature of this outbreak so far, CDC recommends only mosquito avoidance measures for travelers to agricultural areas of Ginosa. These measures include using insect repellent when outdoors, staying in an air-conditioned or well-screened area, and sleeping under an insecticide-treated bed net. CDC will continue to monitor the malaria situation in Italy and will update these recommendations as needed.
See the CDC malaria website for additional health information about malaria, including prevention of mosquito bites and drugs for malaria prevention. For general health information for travelers to all areas of the world, see the CDC Travelers’ Health website.
After five long years, malaria is back with a vengeance in Delhi and the number of cases has shot up alarmingly to 113
Thursday, June 29th, 2017WHO: New vector control response seen as game-changer
Friday, June 2nd, 2017The call came from the WHO Director-General in May 2016 for a renewed attack on the global spread of vector-borne diseases.
“What we are seeing now looks more and more like a dramatic resurgence of the threat from emerging and re-emerging infectious diseases,” Dr Margaret Chan told Member States at the Sixty-ninth World Health Assembly. “The world is not prepared to cope.”
Dr Chan noted that the spread of Zika virus disease, the resurgence of dengue, and the emerging threat from chikungunya were the result of weak mosquito control policies from the 1970s. It was during that decade that funding and efforts for vector control were greatly reduced.
‘Vector control has not been a priority’
Dr Ana Carolina Silva Santelli has witnessed this first-hand. As former head of the programme for malaria, dengue, Zika and chikungunya with Brazil’s Ministry of Health, she saw vector-control efforts wane over her 13 years there. Equipment such as spraying machines, supplies such as insecticides and personnel such as entomologists were not replaced as needed. “Vector control has not been a priority,” she said.
Today more than 80% of the world’s population is at risk of vector-borne disease, with half at risk of two or more diseases. Mosquitoes can transmit, among other diseases, malaria, lymphatic filariasis, Japanese encephalitis and West Nile; flies can transmit onchocerciasis, leishmaniasis and human African trypanosomiasis (sleeping sickness); and bugs or ticks can transmit Chagas disease, Lyme disease and encephalitis.
Together, the major vector-borne diseases kill more than 700 000 people each year, with populations in poverty-stricken tropical and subtropical areas at highest risk. Other vector-borne diseases, such as tick-borne encephalitis, are of increasing concern in temperate regions.
Rapid unplanned urbanization, massive increases in international travel and trade, altered agricultural practices and other environmental changes are fuelling the spread of vectors worldwide, putting more and more people at risk. Malnourished people and those with weakened immunity are especially susceptible.
A new approach
Over the past year, WHO has spearheaded a new strategic approach to reprioritize vector control. The Global Malaria Programme and the Department of Control of Neglected Tropical Diseases – along with the Special Programme for Research and Training in Tropical Diseases, have led a broad consultation tapping into the experience of ministries of health and technical experts. The process was steered by a group of eminent scientists and public health experts led by Dr Santelli and Professor Thomas Scott from the Department of Entomology and Nematology at the University of California, Davis and resulted in the Global Vector Control Response (GVCR) 2017–2030.
At its Seventieth session, the World Health Assembly unanimously welcomed the proposed response.
The GVCR outlines key areas of activity that will radically change the control of vector-borne diseases:
- Aligning action across sectors, since vector control is more than just spraying insecticides or delivering nets. That might mean ministries of health working with city planners to eradicate breeding sites used by mosquitoes;
- Engaging and mobilizing communities to protect themselves and build resilience against future disease outbreaks;
- Enhancing surveillance to trigger early responses to increases in disease or vector populations, and to identify when and why interventions are not working as expected; and
- Scaling-up vector-control tools and using them in combination to maximize impact on disease while minimizing impact on the environment.
Specifically, the new integrated approach calls for national programmes to be realigned so that public health workers can focus on the complete spectrum of relevant vectors and thereby control all of the diseases they cause.
Recognizing that efforts must be adapted to local needs and sustained, the success of the response will depend on the ability of countries to strengthen their vector-control programmes with financial resources and staff.
A call to pursue novel interventions aggressively
The GVCR also calls for the aggressive pursuit of promising novel interventions such as devising new insecticides; creating spatial repellents and odour-baited traps; improving house screening; pursuing development of a common bacterium that stops viruses from replicating inside mosquitoes; and modifying the genes of male mosquitoes so that their offspring die early.
Economic development also brings solutions. “If people lived in houses that had solid floors and windows with screens or air conditioning, they wouldn’t need a bednet,” said Professor Scott. “So, by improving people’s standard of living, we would significantly reduce these diseases.”
The call for a more coherent and holistic approach to vector control does not diminish the considerable advances made against individual vector-borne diseases.
Malaria is a prime example. Over the past 15 years, its incidence in sub-Saharan Africa has been cut by 45% – primarily due to the massive use of insecticide-treated bed nets and spraying of residual insecticides inside houses.
But that success has had a down side.
“We’ve been so successful, in some ways, with our control that we reduced the number of public health entomologists – the people who can do this stuff well,” said Professor Steve Lindsay, a public health entomologist at Durham University in Britain. “We’re a disappearing breed.”
The GVCR calls for countries to invest in a vector-control workforce trained in public health entomology and empowered in health care responses.
“We now need more nuanced control – not one-size-fits-all, but to tailor control to local conditions,” Professor Lindsay said. This is needed to tackle new and emerging diseases, but also to push towards elimination of others such as malaria, he said.
Dr Lindsay noted that, under the new strategic approach, individual diseases such as Zika, dengue and chikungunya will no longer be considered as separate threats. “What this represents is not three different diseases, but one mosquito – Aedes aegypti,” said Professor Lindsay.
GVCR dovetails with Sustainable Development Goals
The GVCR will also help countries achieve at least 6 of the 17 Sustainable Development Goals. Of direct relevance are goal 3 on good health and well-being, goal 6 on clean water and sanitation, and goal 11 on sustainable cities and communities.
The GVCR goals are ambitious – to reduce mortality from vector-borne diseases by at least 75% and incidence by at least 60% by 2030 – and to prevent epidemics in all countries.
The annual price tag is US$ 330 million globally, or about 5 cents per person – for workforce, coordination and surveillance costs. This is a modest additional investment in relation to insecticide-treated nets, indoor sprays and community-based activities, which usually exceed US$ 1 per person protected per year.
It also represents less than 10% of what is currently spent each year on strategies to control vectors that spread malaria, dengue and Chagas disease alone. Ultimately, the shift in focus to integrated and locally adapted vector control will save money.
‘A call for action’
Dr Santelli expressed optimism that the GVCR will help ministries of health around the world gain support from their governments for a renewed focus on vector control.
“Most of all, this document is a call for action,” said Dr Santelli, who now serves as deputy director for epidemiology in the Brasilia office of the U.S. Centers for Disease Control and Prevention.
It will not be easy, she predicts. The work to integrate vector-control efforts across different diseases will require more equipment, more people and more money as well as a change in mentality. “The risk of inaction is greater,” said Dr Santelli, “given the growing number of emerging disease threats.” The potential impact of the GVCR is immense: to put in place new strategies that will reduce overall burden and, in some places, even eliminate these diseases once and for all.
Serious and fatal bouts of malaria in the United States are a greater problem than has been previously reported
Sunday, April 30th, 2017The study was published Monday by The American Journal of Tropical Medicine and Hygiene.
The authors counted 22,000 patients hospitalized for malaria, about five times as many as were hospitalized, for example, for dengue fever….. Nearly 5,000 of them had serious complications like kidney failure or coma, and 182 died.
The world’s first vaccine against malaria will be introduced in three countries – Ghana, Kenya and Malawi – starting in 2018.
Monday, April 24th, 2017“….Despite huge progress, there are still 212 million new cases of malaria each year and 429,000 deaths…..”